Litcius/Paper detail

Repositioning of histamine H1 receptor antagonist: Doxepin inhibits viropexis of SARS-CoV-2 Spike pseudovirus by blocking ACE2

Shuai Ge, Xiangjun Wang, Yajing Hou, Yuexin Lv, Chéng Wáng, Huaizhen He

2021European Journal of Pharmacology39 citationsDOIOpen Access PDF

Topics & Concepts

DoxepinHistaminePharmacologyAngiotensin-converting enzyme 2Histamine H1 receptorHistamine receptorCoronavirusReceptorAntagonistChemistryVirologyMedicineCoronavirus disease 2019 (COVID-19)Internal medicineBiochemistryDiseaseInfectious disease (medical specialty)SARS-CoV-2 and COVID-19 ResearchMast cells and histamineImmunotherapy and Immune Responses
Repositioning of histamine H1 receptor antagonist: Doxepin inhibits viropexis of SARS-CoV-2 Spike pseudovirus by blocking ACE2 | Litcius